Differential patterns of central synucleinopathy and catecholaminergic abnormalities in Lewy body diseases and multiple system atrophy.

Emerging Role of Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory Evaluation of Chronic Autonomic Failure.

Pure autonomic failure as an essential window into progression of synucleinopathies.

Should Neurogenic Supine Hypertension Be Treated? Insights from Hypertension-Mediated Organ Damage Studies-A Narrative Review.

Long COVID as Intermediate Physiology: Rethinking Autonomic Dysfunction and Medical Uncertainty.

Association of Autonomic Dysfunction With Long COVID: Evaluation Using Quantitative Autonomic Testing.

Quality of life and disability in pure autonomic failure: More than a prodromal synucleinopathy.

Establishing minimally clinically important differences for the orthostatic hypotension questionnaire (OHQ).

Idiopathic polyneuropathy with neurogenic autonomic failure - an early manifestation of Lewy body disease? a case report.

Cardiac MIBG scintigraphy in pure autonomic failure: A systematic review.

Multitracer PET to Assess Cardiac Sympathetic Innervation and Vesicular Storage in Lewy Body Diseases.

Approach to Cardiovascular Autonomic Dysfunction in Patients with Synucleinopathies.

Cardiac 123I-Meta-Iodobenzylguanidine Imaging as a Biomarker for Body-First Parkinson's Disease: Linking Peripheral α-Synuclein to Clinical Subtyping.

Harlequin syndrome: using clinical features and autonomic testing to unmask the disorder.

Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure.

Autonomic nervous system dysregulation in neurodegenerative diseases: Bridging brain and heart.

The MSA Atrophy Index (MSA-AI): An Imaging Marker for Diagnosis and Clinical Progression in Multiple System Atrophy.

Crosstalk between bladder-cardiovascular autonomic nervous system in synucleinopathies.

Prevalence of Supine Hypertension in Alpha-Synucleinopathies: A Systematic Review and Meta-Analysis.

Pure autonomic failure: a natural history study of the Queen Square cohort.

The Usefulness of 131 I-MIBG Myocardial Scintigraphy in a Case of Pure Autonomic Failure - First Report in the Literature.

Pure autonomic failure, phenoconversion phenomenon and autonomic non-motor subtype of Parkinson disease: The chicken or the egg?

The phenotype of "pure" autonomic failure.

Sustained therapeutic effect of spinal cord stimulation on improving severe neurogenic orthostatic hypotension in a patient with pure autonomic failure converting to multiple system atrophy.

Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin-Sensitive Magnetic Resonance Imaging and 18F-Fluorodopa-Positron Emission Tomography.

Pathophysiological Significance of α-Synuclein in Sympathetic Nerves: In Vivo Observations.

Clinical Correlates of Efficacy of Pyridostigmine in the Treatment of Orthostatic Hypotension.

Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies.

A-synuclein prion strains differentially adapt after passage in mice.

Cutaneous phosphorylated-synuclein: an early diagnostic biomarker for pure autonomic failure.

SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms.

Pelvic autonomic dysfunction is common in patients with pure autonomic failure.

Intrasubject reproducibility of supine norepinephrine plasma concentrations in patients with cardiovascular sympathetic failure.

Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies.

Cerebrospinal fluid concentration gradients of catechols in synucleinopathies.

An update on multiple system atrophy.

Parkinson's Disease and Dementia with Lewy Bodies: One and the Same.

Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.

Clinical Characteristics and Outcomes in Young-Onset Multiple System Atrophy.

Tilt-evoked, breathing-driven blood pressure oscillations: Independence from baroreflex-sympathoneural function.

Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study.

Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment.

Hemodynamic recognition of pure autonomic failure: A case report.

An overview on pure autonomic failure.

Primary Sjogren's syndrome presenting as an isolated severe autonomic dysfunction treated with steroids.

Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement.

Hemodynamic Effects of the Osmopressor Response: A Systematic Review and Meta-Analysis.

Cardiac 18F-dopamine positron emission tomography predicts the type of phenoconversion of pure autonomic failure.

Autonomic failure: Clinicopathologic, physiologic, and genetic aspects.

Exploring the impact of caring for an individual with neurogenic orthostatic hypotension: a qualitative study.

Post-Traumatic Stress Disorder and Risk of Degenerative Synucleinopathies: Systematic Review and Meta-Analysis.

Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction.

D-685 Reverses Motor Deficits and Reduces Accumulation of Human α-Synuclein Protein in Two Different Parkinson's Disease Animal Models.

Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid.

Continuous Positive Airway Pressure for the Treatment of Supine Hypertension and Orthostatic Hypotension in Autonomic Failure.

Imaging in autonomic failure: a window into real-time physiological mechanisms and other updates on recent autonomic research.

Health-related quality-of-life and burden for caregivers of individuals with neurogenic orthostatic hypotension.

Real-Time Magnetic Resonance Imaging to Study Orthostatic Intolerance Mechanisms in Human Beings: Proof of Concept.

Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy.

Pure Autonomic Failure-A Localized Alpha Synucleinopathy with a Potential for Conversion to More Extensive Alpha Synucleinopathies.

Renal Transplantation in Pure Autonomic Failure.

[Evaluation of Disopyramide Efficacy for Refractory Syncope in Heart Failure with Preserved Ejection Fraction Using Holter Electrocardiography: A Case Report].

Cerebrovascular regulation in patients with vasovagal syncope and autonomic failure due to familial amyloidotic polyneuropathy.

Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.

Diagnosing Premotor Multiple System Atrophy: Natural History and Autonomic Testing in an Autopsy-Confirmed Cohort.

[Dizziness upon standing: consider autonomic dysfunction].

A Case of Pure Autonomic Failure Initially Presenting with Hemihypohidrosis: Twelve-Year Follow-Up.

Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies.

Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.

[Autonomic Dysfunction in Lewy Body Disease].

[Pathological Study of Pure Autonomic Failure].

Passive Immunization in Alpha-Synuclein Preclinical Animal Models.

Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure?

Relationships Between Cardiovascular Autonomic Profile and Work Ability in Patients With Pure Autonomic Failure.

Pure autonomic failure: the first report in Poland?

[A case of pure autonomic failure that eventually developed into multiple system atrophy 5 years later].

The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.

Inhibition of the norepinephrine transporter to treat neurogenic orthostatic hypotension: is this the end of the story?

Lewy pathology of the submandibular gland in Lewy body disease: A report of autopsy cases.

Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.

Pure Autonomic Failure: A Case Report of Recurrent Orthostatic Hypotension.

Pure autonomic failure and the differential diagnosis of autonomic peripheral neuropathies.

Cardiology meets neurology: clinical presentation and management of patients with primary neurogenic disorders and orthostatic intolerance.

Synuclein in neurodegeneration.

Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension.

The new frontier in pure autonomic failure: getting a grip on cerebral blood flow.

Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.

Dysautonomia: A Forgotten Condition - Part 1.

Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure.

Local Passive Heat for the Treatment of Hypertension in Autonomic Failure.

Do indices of baroreflex failure and peripheral noradrenergic deficiency predict the magnitude of orthostatic hypotension in Lewy body diseases?

Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.

Elevated cerebral blood flow in patients with pure autonomic failure.

Can novel non-invasive autonomic tests help discriminate between pure autonomic failure and multiple system atrophy?

Clinical and neurohormonal characteristics in African Americans with neurogenic orthostatic hypotension.

Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies.

Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases.

Repeated hypoglycemia remodels neural inputs and disrupts mitochondrial function to blunt glucose-inhibited GHRH neuron responsiveness.

Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.

Pharmacologic treatment of orthostatic hypotension.

Cardiac sympathetic innervation and vesicular storage in pure autonomic failure.

The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases.

Autonomic Dysfunction in the Synucleinopathies.

Cerebrospinal fluid fistula in a patient with chronic constipation related to an autonomic dysfunction and revealed by bacterial meningitis - A case report.

Is Ross Syndrome a New Type of Synucleinopathy? A Brief Research Report.

Predicting phenoconversion in pure autonomic failure.

The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension.

An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention.

"Sick-but-not-dead": multiple paths to catecholamine deficiency in Lewy body diseases.

Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.

Mechanisms of alpha-synuclein toxicity: An update and outlook.

Diagnosing multiple system atrophy at the prodromal stage.

Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy.

Synucleinopathies: Where we are and where we need to go.

Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment.

The catecholaldehyde hypothesis: where MAO fits in.

Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies.

Autonomic dysfunction: Diagnosis and management.

Orthostatic Hypotension in Parkinson Disease.

Sensitivity and specificity of cardiac 123I-MIBG scintigraphy for diagnosis of early-phase Parkinson's disease.

Long-term trends in myocardial sympathetic innervation and function in synucleinopathies.

Cognitive and Behavioral Changes in Patients Treated With Droxidopa for Neurogenic Orthostatic Hypotension: A Retrospective Review.

Pure autonomic failure presenting as Harlequin syndrome.

A case of autonomic failure in post-craniectomy syndrome of the trephined.

Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers.

Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies.

Role of nurses and nurse practitioners in the recognition, diagnosis, and management of neurogenic orthostatic hypotension: a narrative review.

Autonomic Dysfunction in α-Synucleinopathies.

Usefulness of Blood Pressure Variability Indices Derived From 24-Hour Ambulatory Blood Pressure Monitoring in Detecting Autonomic Failure.

Dopamine transporter imaging versus myocardial MIBG scintigraphy for the diagnosis of prodromal synucleinopathies-and other updates on autonomic research.

Droxidopa for Hypotension of Different Etiologies: Two Case Reports.

Blood pressure circadian rhythm alterations in alpha-synucleinopathies.

MIBG Myocardial Scintigraphy Identifies Premotor PD/DLB During a Negative DAT Scan Period: Second Report.

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases.

Moving forward the in vivo diagnosis of the synucleinopathies.

Pure Autonomic Failure with Asymptomatic Hypertensive Urgency: A Case Report and Literature Review.

Skin nerve α-synuclein deposits in Parkinson's disease and other synucleinopathies: a review.

Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study.

Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.

Orthostatic Hypotension: JACC State-of-the-Art Review.

Characterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregivers.

Roles of cardiac sympathetic neuroimaging in autonomic medicine.

Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.

Autonomic dysfunction in genetic forms of synucleinopathies.

Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.

Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies.

Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure.

Sympathetic neurograms showing characteristics of both muscle and skin sympathetic nerve activity in a case with pure autonomic failure.

Autonomic dysfunction predicts poor outcome in stroke: Updates on recent autonomic research.

Neuropathology of autonomic dysfunction in synucleinopathies.

The effects of recurrent hypoglycaemia and opioid antagonists on the adrenal catecholamine synthetic capacity in a rat model of HAAF.

Does sympathetic dysfunction occur before denervation in pure autonomic failure?

Diagnosis of multiple system atrophy.

Symptomatic therapy of multiple system atrophy.

Treatment of supine hypertension in autonomic failure: a case series.

The heart of PD: Lewy body diseases as neurocardiologic disorders.

Hypothalamic Glucose Transport in Humans During Experimentally Induced Hypoglycemia-Associated Autonomic Failure.

Let's not forget about the vagus and other updates on recent autonomic research.

Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.

Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease.

Possible Involvement of Hypotension in Postprandial Headache: A Case Series.

Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.

Droxidopa for Symptomatic Neurogenic Hypotension.

Iodine-123-meta-iodobenzylguanidine Myocardial Scintigraphy in Isolated Autonomic Failure: Potential Red Flag for Future Multiple System Atrophy.

REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.

Letter on "Natural history of pure autonomic failure: A United States prospective cohort".

Very late-onset pure autonomic failure.

Is pure autonomic failure a distinct nosologic entity?

Is pure autonomic failure an early marker for Parkinson disease, dementia with Lewy bodies, and multiple system atrophy? And other updates on recent autonomic research.

Pure autonomic failure without alpha-synuclein pathology: an evolving understanding of a heterogeneous disease.

Pure autonomic failure: Predictors of conversion to clinical CNS involvement.

Pure autonomic failure without synucleinopathy.

Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside.

Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension.

Natural history of pure autonomic failure: A United States prospective cohort.

The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.

The Pharmacology of Autonomic Failure: From Hypotension to Hypertension.

Autoimmunity-associated autonomic failure with sympathetic denervation.

Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303).

A case series of REM sleep behavior disorder in pure autonomic failure.

Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension.

Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension.

Superficial siderosis associated with peripheral autonomic failure and tetraventricular hydrocephalus: a case report.

Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.

Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.

Congenital Insensitivity to Pain (HSNA type IV).

(123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies.

Mineralocorticoid Receptor Activation Contributes to the Supine Hypertension of Autonomic Failure.

Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease.

[Acute Sensory Neuropathies and Acute Autonomic Neuropathies].